Stockscreener 앱 받기
12.29
2.26%
0.34
시간 외 거래:
12.21
-0.08
-0.65%
전일 마감가:
$11.95
열려 있는:
$12.02
하루 거래량:
43,704
Relative Volume:
0.84
시가총액:
$78.93M
수익:
$169.43M
순이익/손실:
$-186.01M
주가수익비율:
-6.0842
EPS:
-2.02
순현금흐름:
$70.07M
1주 성능:
+5.16%
1개월 성능:
+31.12%
6개월 성능:
-1.30%
1년 성능:
-5.56%
1일 변동 폭
$11.56
$12.30
1주일 범위
$11.43
$12.95
52주 변동 폭
$7.7055
$15.15
애서티오 홀딩스 Stock (ASRT) Company Profile
명칭
Assertio Holdings Inc
전화
(224) 419-7106
주소
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
12.30 | 76.68M | 169.43M | -186.01M | 70.07M | -2.02 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.38 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.63 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.92 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
476.07 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
애서티오 홀딩스 Stock (ASRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-26 | 개시 | Maxim Group | Buy |
| 2024-07-03 | 개시 | H.C. Wainwright | Buy |
| 2022-11-07 | 개시 | Lake Street | Buy |
| 2018-11-30 | 다운그레이드 | Mizuho | Buy → Neutral |
애서티오 홀딩스 주식(ASRT)의 최신 뉴스
US Market Wrap: Can Assertio Holdings Inc maintain sales growthTrade Exit Summary & Safe Capital Preservation Plans - baoquankhu1.vn
Why Assertio Holdings Inc. stock is rated strong buyGap Down & Long-Term Safe Investment Ideas - mfd.ru
Value Recap: Is Assertio Holdings Inc a strong candidate for buy and hold2025 Pullback Review & Weekly High Potential Stock Alerts - baoquankhu1.vn
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry - simplywall.st
What Could Shift The Assertio Holdings ASRT Narrative After Recent Updates And Peer Signals - Yahoo Finance
Assertio (NASDAQ:ASRT) Stock Price Up 3.9%Here's What Happened - MarketBeat
Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High? - Finviz
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 28% Share Price Rise - 富途牛牛
Can Assertio Holdings Inc. maintain sales growthWeekly Profit Recap & Capital Protection Trading Alerts - mfd.ru
Pullback Watch: Is Assertio Holdings Inc stock risky to hold now2025 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Pullback Watch: Does Assertio Holdings Inc have declining or rising EPSMarket Growth Review & Daily Volume Surge Signals - baoquankhu1.vn
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet - sharewise.com
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Assertio regains nasdaq compliance after successful reverse split By Investing.com - Investing.com Nigeria
Assertio regains compliance with Nasdaq minimum bid price requirement - Investing.com India
Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Decreases By 92.8% - MarketBeat
Assertio Therapeutics announces 1-for-15 reverse stock split - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement By Investing.com - Investing.com Nigeria
Assertio regains Nasdaq compliance after bid price recovery - MSN
Assertio regains nasdaq compliance after successful reverse split - Investing.com
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - The Joplin Globe
Los Angeles Daily NewsAssertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - FinancialContent
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story - Yahoo Finance
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing - Intellectia AI
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - The Joplin Globe
Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan
Why Assertio Holdings Inc. stock is trending among retail traders2025 Investor Takeaways & AI Forecast Swing Trade Picks - Улправда
Why Assertio Holdings Inc. stock remains a top recommendationForecast Cut & Real-Time Sentiment Analysis - Улправда
What momentum indicators show for Assertio Holdings Inc. stockJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
FY2025 EPS Estimates for Assertio Raised by HC Wainwright - Defense World
FY2025 EPS Estimates for Assertio Increased by HC Wainwright - MarketBeat
HC Wainwright Forecasts Assertio’s Q4 Earnings (NASDAQ:ASRT) - Defense World
What is HC Wainwright's Forecast for Assertio Q4 Earnings? - MarketBeat
Support Test: Can Assertio Holdings Inc stock deliver 10 annual returnsMarket Performance Recap & Weekly Watchlist of Top Performers - moha.gov.vn
H.C. Wainwright raises Assertio stock price target to $35 following reverse split - Investing.com Canada
H.C. Wainwright raises Assertio stock price target to $35 following reverse split By Investing.com - Investing.com South Africa
Assertio (NASDAQ:ASRT) Upgraded at Zacks Research - Defense World
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Assertio (NASDAQ:ASRT) Raised to Strong-Buy at Zacks Research - MarketBeat
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - marketscreener.com
Assertio Holdings announces 1-for-15 reverse stock split - MSN
ASSERTIO HOLDINGS INC Financial Disclosures & Filings - TradingView — Track All Markets
애서티오 홀딩스 (ASRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
애서티오 홀딩스 주식 (ASRT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schwichtenberg Paul | President and COO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
12,834 |
| Patel Ajay | EVP and CFO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
14,789 |
| Stark David Matthew | Director |
Nov 10 '25 |
Sale |
0.76 |
8,959 |
6,806 |
98,541 |
0.53%
10.56%
자본화:
|
볼륨(24시간):